Arcutis Biotherapeutics Inc — Cash Flow (NASDAQ:ARQT) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics Dividends

Quarterly Annual

Cash from operating activities 113.03 M174.63 M257.71 M247.06 M112.16 M5.63 M 5.63 M Cash from investing activities 181.82 M75.95 M87.2 M180.23 M28.82 M30.25 M 30.25 M Cash from financing activities 298.14 M281.95 M301.8 M101.32 M66.2 M6.97 M 6.97 M Free cash flow 112.71 M173.63 M249.88 M246.63 M107.02 M-5.06 M 4.94 M

Nouvelles

Miners Barrick, Pan American Leads 10 Hot Growth Stocks Onto The IBD 50, Other Premium Lists

Stock Market Can't Hold Key Levels Amid AI Concerns; Nvidia Tumbles Despite Strong Earnings: Weekly Review

Drug Stocks Lead Eight Hot New Names Onto IBD 50 List, Big Cap 20 And More

Needham relève l’objectif de cours d’Arcutis à 36$ sur fond de ventes solides

Needham raises Arcutis stock price target to $36 on strong sales

H.C. Wainwright relève l’objectif de cours d’Arcutis sur fond de ventes solides de Zoryve

H.C. Wainwright raises Arcutis stock price target on strong Zoryve sales

Arcutis Biotherapeutics, Inc. (ARQT) Surpasses Q4 Earnings and Revenue Estimates

Arcutis T4 2025 : ZORYVE génère la rentabilité, revenus dépassent les attentes

Arcutis Q4 2025 slides: ZORYVE drives profitability, revenue beats

Dow Jones Futures Fall Despite Strong Nvidia Earnings After S&P 500 Reclaims Key Level

Arcutis earnings beat by $0.05, revenue topped estimates